Search clinical trials for: 68Ga-DOTA-TATE

Total 4871 results

Novartis Pharmaceuticals
Eckert & Ziegler Radiopharma GmbH

Recruiting

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Neuroendocrine Neoplasms

Japan
Andrei Iagaru

No longer available

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Carcinoid Tumors | Islet Cell (Pancreatic NET) | Other Neuroendocrine Tumors

United States
Centre de recherche du Centre hospitalier universitaire...
Université de Sherbrooke

Recruiting

68Ga-DOTA-TATE PET/CT Imaging in NETs

Neuroendocrine Tumors

Canada
Peking Union Medical College Hospital

Recruiting

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Lung Cancer | Neuroendocrine Neoplasm

China
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-FAPI PET/CT in Patients With Various Types of Cancer

Metastasis | Tumor | Positron-Emission Tomography

China
Wuhan Union Hospital, China

Recruiting

Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia

Neuroendocrine Tumors | Osteomalacia | PET / CT | PET / MR

China
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)

177Lu-DOTA-FAPI | 68Ga-DOTA-FAPI | Theranostic

China
Medical University Innsbruck
Novartis

Completed

68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

Neuroendocrine Tumors

Austria
Peking Union Medical College Hospital

Not yet recruiting

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

Breast Cancer

China
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Terminated

68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Italy
Peking Union Medical College Hospital

Unknown

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Lymphatic Disorders

China
The First Affiliated Hospital of Xiamen University

Recruiting

PET Imaging of LAG-3 Expression

Tumor, Solid

China
Peking Union Medical College Hospital

Unknown

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

Tumor-Induced Osteomalacia

China
Peking Union Medical College Hospital

Unknown

68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis

Pulmonary Fibrosis, Unspecified

China
Peking Union Medical College Hospital

Recruiting

Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Neuroendocrine Tumors

China
The First Affiliated Hospital of Soochow University

Not yet recruiting

PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells

Lymphoma
University of California, Davis
United States Department of Defense

Recruiting

Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

Metastatic Nonsmall Cell Lung Cancer

United States
University of California, Davis
National Institutes of Health (NIH)

Recruiting

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

Metastatic Cancer

United States
Peking Union Medical College Hospital

Recruiting

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

Neuroendocrine Tumors

China
University of California, Davis

Recruiting

First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer

Locally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer

United States
Peking Union Medical College Hospital

Unknown

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Neuroendocrine Tumors

China
Instituto Nacional de Cancerologia, Columbia

Completed

Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate

Neuroendocrine Tumors

Colombia
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Neuroendocrine Tumors

China
Nanjing First Hospital, Nanjing Medical University

Completed

Clinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma

China
SmartNuclide Biopharma
The First Affiliated Hospital of Soochow University

Recruiting

[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors

Solid Tumor | Positron-Emission Tomography(PET)

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients

Breast Cancer

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients

Prostate Cancer

China
Novartis Pharmaceuticals

Not yet recruiting

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Metastatic Neuroendocrine Prostate Cancer
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases

Positron-Emission Tomography

China
Rigshospitalet, Denmark

Completed

Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer

Head and Neck Cancer

Denmark
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction (GRGDMI)

Coronary Artery Disease

China
Peking Union Medical College Hospital
Beijing Tiantan Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma (GRGDG)

Glioma

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB

Lymphedema | Hemangioma | Arteriovenous Malformation | Neoplasms Lymph Nodes

China
Turku University Hospital

Active, not recruiting

Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis (SIGLEC)

Rheumatoid Arthritis | Vasculitis | Healthy Subjects | Pulmonary Sarcoidosis

Finland
The First Affiliated Hospital of Xiamen University

Completed

Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer

Tumor, Solid, FAPI, PET/CT, Metastasis

China
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients (GRGDLC)

Lung Cancer

China
AHS Cancer Control Alberta
Cross Cancer Institute

Active, not recruiting

Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014

Neuroendocrine Tumors, NET

Canada
Novartis Pharmaceuticals

Recruiting

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

Glioblastoma

Spain, Switzerland, France, Portugal, United States
Cytosite Biopharma Inc.
University of Alabama at Birmingham

Completed

Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers.

Healthy Volunteers

United States
Rigshospitalet, Denmark

Recruiting

uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung

Non-small Cell Lung Cancer | Malignant Pleural Mesothelioma | Large Cell Neuroendocrine Carcinoma of the Lung

Denmark
Rigshospitalet, Denmark

Unknown

uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness

Prostate Cancer

Denmark
AHS Cancer Control Alberta

Recruiting

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

Carcinoma, Neuroendocrine

Canada
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas

Glioma

China
Huashan Hospital

Recruiting

[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer

Non-small Cell Lung Cancer

China
Huashan Hospital

Recruiting

Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors

Neoplasms | Positron-Emission Tomography

China
Huashan Hospital

Recruiting

A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
SmartNuclide Biopharma

Recruiting

Phase I Clinical Trial of 68Ga-NOTA-SNA002

Solid Tumor | Positron-Emission Tomography(PET)

China
Centre de recherche du Centre hospitalier universitaire...

Completed

Study to Measure the Safety of 68Ga-DOTA-TATE PET/CT in the Diagnosis of Tumors Expressing Somatostatin Receptors (PET/Ga68)

Neuroendocrine Tumors

Canada
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis (GRGDRA)

Rheumatoid Arthritis

China
Xijing Hospital

Unknown

68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients (GNNGB)

Glioma | Breast Cancer

China

Search clinical trials for: 68Ga-DOTA-TATE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations